Introduction
Gwo Xi Company has established USFDA DMF-verified, clinical-grade mesenchymal stem cell (MSC) line, which serve as ideal starting materials for regenerative medicine product development. The cell line can be further applied in stem cell-based therapeutics, vector development, exosome R&D, and drug screening.
Through rigorous quality control and a comprehensive cell bank management system, we ensure full compliance, including donor traceability, suitability testing, IRB approval, and adventitious virus testing. Our cells are manufactured in a PIC/S GMP-compliant facility. With our extensive experience in clinical applications and regulatory filings, we help clients eliminate concerns regarding ethics and safety, while simplifying complex application procedures to significantly accelerate product development.
Features / strengths
．Complete cell bank and quality control
．2 experienced in Domestic and International clinical trials
．Diversified cell line establishment platform
．USFDA DMF-compliance
．Including cold-chain logistics
Specification in detail
Material
Human Adipose-derived stem cells (hADSCs)
Application
Stem cell therapy & Exosome products development
Supporting document
